Biotech · Private company
LimmaTech Biologics AG
Track this companyFree. Adds LimmaTech Biologics AG to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Flexyn2aPhase 2 · ShigellosisClinicalTrials.gov · fetched Nov 12, 2026
- Shigella4V2Phase 2 · ShigellosisClinicalTrials.gov · fetched Nov 12, 2026
- LTB-SA7Phase 1 · Staphylococcus (S.) Aureus InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.PHASE1 · COMPLETED · started Jan 7, 2025ClinicalTrials.gov NCT06719219 · fetched Nov 12, 2026
- A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate VaccinePHASE2 · COMPLETED · started Nov 12, 2024ClinicalTrials.gov NCT06615375 · fetched Nov 12, 2026
- Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2aPHASE2 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02646371 · fetched Nov 12, 2026